Saturday 17 October 2026
Export NNOX’s income statement to Excel — free account
Nano-X Imaging Ltd.
NNOX Healthcare Medical Devices
Nano-X Imaging Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $13.0 million, up 15.4% from fiscal 2024. In the quarter to June 2026, revenue grew 36.7%, EPS fell 243.5%, free cash flow fell 21.4% and total debt fell 12.0%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
0.45
0.04
−8.16%
Follow NNOX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | 3 | 4 | 3 |
| (34.75%) | (45.62%) | (50.12%) | (98.98%) | ||
| (30.95%) | (40.31%) | (44.40%) | (84.82%) | ||
ROIC |
(31.48%) | (52.17%) | (57.58%) | (168.62%) | |
Return on Tangible Assets |
(65.02%) | (94.27%) | (112.22%) | (205.34%) | |
Average Days of Receivables |
57.47 | 56.43 | 55.54 | 44.06 | |
Free Cash Flow per Share |
(0.70) | (0.69) | (0.72) | (0.74) | |
Free Cash Flow |
(45.27) | (45.00) | (49.88) | (52.09) | |
Capital Expenditures |
(4.36) | (4.21) | (5.46) | (5.39) | |
| Other line items | |||||
Cash ROIC |
(22.07%) | (23.44%) | (28.81%) | (48.95%) | |
Accounts Receivable Turnover |
7.18 | 6.82 | 7.39 | 8.30 | |
Accounts Payable Turnover |
17.76 | 10.13 | 12.38 | 30.92 | |
Inventory Turnover |
13.17 | 11.31 | 10.69 | 24.13 | |
Average Days of Payables |
21.15 | 40.81 | 32.55 | 11.41 | |
Days of Inventory on Hand |
39.97 | 43.42 | 44.52 | 18.24 | |
Tax Rate |
0.00 | (0.02) | (0.02) | (0.01) | |
Research and Development Expense of Revenue |
160.94% | 147.73% | 131.27% | 121.08% | |
Selling, General and Administrative Expense of Revenue |
210.39% | 209.29% | 196.87% | 189.07% | |
Share Based Compensation of Revenue |
38.95% | 32.18% | 26.62% | 23.18% | |
Operating CF/Net income |
0.73 | 0.54 | 0.58 | 0.40 | |
Depreciation/Fixed assets |
0.25 | 0.40 | 0.38 | 0.36 | |
Capex/Depreciation |
(0.37) | (0.36) | (0.47) | (0.47) | |
Revenue per Share |
0.19 | 0.20 | 0.21 | 0.22 | |
Operating CF per Share |
(0.64) | (0.63) | (0.64) | (0.67) | |
Capex per Share |
(0.07) | (0.06) | (0.08) | (0.08) | |
Capex to Sales |
0.35 | 0.32 | 0.38 | 0.34 |
Columns are period end dates